Neutral Block Copolymer Assisted Gene delivery using Hydrodynamic Limb Vein Injection.

block copolymers gene delivery hydrodynamic injection polyglycidol polyoxazoline

Journal

Macromolecular bioscience
ISSN: 1616-5195
Titre abrégé: Macromol Biosci
Pays: Germany
ID NLM: 101135941

Informations de publication

Date de publication:
21 Mar 2024
Historique:
revised: 13 03 2024
received: 12 12 2023
medline: 21 3 2024
pubmed: 21 3 2024
entrez: 21 3 2024
Statut: aheadofprint

Résumé

Three different amphiphilic block copolymer families were synthesized to investigate new opportunities to enhance gene delivery via Hydrodynamic Limb Vein (HLV) injections. First a polyoxazoline-based family containing mostly one poly(2-methyl-2-oxazoline) (PMeOx) block and a second block POx with an ethyl (EtOx), isopropyl (iPrOx) or phenyl substituent (PhOx) has been synthesized. Then an ABC poly(2-ethyl-2-oxazoline)-b-poly(2-n-propyl-2-oxazoline)-b-poly(2-methyl-2-oxazoline) triblock copolymer was synthesized, with a thermosensitive middle block. Finally, polyglycidol-b-polybutylenoxide-b-polyglycidol copolymers with various molar masses and amphiphilic balance were produced. The simple architecture of neutral amphiphilic triblock copolymer is not sufficient to obtain enhanced in vivo gene transfection. Double or triple amphiphilic neutral block copolymers are improving the in vivo transfection performances through HLV administration as far as a block having an LCST is incorporated in the vector. The molar mass of the copolymer does not seem to affect the vector performances in a significant manner. This article is protected by copyright. All rights reserved.

Identifiants

pubmed: 38512438
doi: 10.1002/mabi.202300568
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300568

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Yann Le Guen (YL)

Univ Brest, INSERM, EFS, UMR 1078, GGB-GTCA Team, Brest, F-29200, France.
CHU de Brest, Service de Génétique Médicale et de Biologie de la Reproduction, Centre de Référence des Maladies Rares Maladies Neuromusculaires, Brest, 29200, France.

Gwendoline Delecourt (G)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.

Tony Le Gall (TL)

Univ Brest, INSERM, EFS, UMR 1078, GGB-GTCA Team, Brest, F-29200, France.

Haiqin Du (H)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.

Nicolas Illy (N)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.

Cécile Huin (C)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.
University of Evry, Evry, France.

Véronique Bennevault (V)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.
University of Evry, Evry, France.

Patrick Midoux (P)

Centre de Biophysique Moléculaire, CNRS UPR4301, Orléans, France.

Tristan Montier (T)

Univ Brest, INSERM, EFS, UMR 1078, GGB-GTCA Team, Brest, F-29200, France.
CHU de Brest, Service de Génétique Médicale et de Biologie de la Reproduction, Centre de Référence des Maladies Rares Maladies Neuromusculaires, Brest, 29200, France.

Philippe Guégan (P)

Institut Parisien de Chimie Moléculaire, Equipe Chimie des Polymères, Sorbonne University, UMR 8232 CNRS, Paris, France.

Classifications MeSH